13G Filing: Jim Tananbaum’s Foresite Capital Buys More Shares of Aerie Pharmaceuticals Inc (AERI)

Page 6 of 11

Page 6 of 11 SEC Filing

1 NAME OF REPORTING PERSONS James Tananbaum (“Tananbaum”)
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [_] (b) [X]
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH REPORTING
PERSON
WITH
5 SOLE VOTING POWER
1,336,443 shares, of which 844,240 shares are directly owned by Foresite Capital Fund II, L.P. (“FCF II”), and 492,203 shares are directly owned by Foresite Capital Fund III, L.P. (“FCF III”).  Tananbaum is the managing member of each of Foresite Capital Management II, LLC (“FCM II”), which is the general partner of FCF II, and Foresite Capital Management III, LLC (“FCM III”), which is the general partner of FCF III.  Tananbaum may be deemed to have sole power to vote these shares.
6 SHARED VOTING POWER
See response to row 5.
7 SOLE DISPOSITIVE POWER
1,336,443 shares, of which 844,240 shares are directly owned by FCF II, and 492,203 shares are directly owned by FCF III.  Tananbaum is the managing member of each FCM II, which is the general partner of FCF II, and FCM III, which is the general partner of FCF III.  Tananbaum may be deemed to have sole power to dispose of these shares.
8 SHARED DISPOSITIVE POWER
See response to row 7.
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON 1,336,443
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
EXCLUDES CERTAIN SHARES [_]
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.1%
12 TYPE OF REPORTING PERSON IN

Follow Aerie Pharmaceuticals Inc (NASDAQ:AERI)

Page 6 of 11